US EditionPublished • loading... • Updated
PURE Bioscience Reports Fiscal First Quarter 2026 Financial Results
Summary by 01net
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
PURE Bioscience Reports Fiscal First Quarter 2026 Financial Results
EL CAJON, Calif.--(BUSINESS WIRE)--$PURE #Antimicrobial--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the fisc... L'articolo PURE Bioscience Reports Fiscal First Quarter 2026 Financial Results è un contenuto originale di 01net.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
